--- title: "Hims & Hers Shares Rebound Friday: What's Driving the Move?" type: "News" locale: "en" url: "https://longbridge.com/en/news/294548547.md" description: "Hims & Hers Health (HIMS) shares rose 2.44% on Friday, rebounding from technical support despite regulatory headwinds. The FTC is reportedly preparing a lawsuit alleging unlawful data sharing with advertisers like Meta and Snap, which HIMS denies as baseless. Trading occurs near the 100-day SMA, with $30.00 identified as key resistance needed to shift the near-term trend bullish." datetime: "2026-07-31T18:41:05.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/294548547.md) - [en](https://longbridge.com/en/news/294548547.md) - [zh-HK](https://longbridge.com/zh-HK/news/294548547.md) generator: "portal-rs" --- # Hims & Hers Shares Rebound Friday: What's Driving the Move? **Hims & Hers Health Inc**. (NYSE:HIMS) shares are trading higher on Friday as traders continue to weigh fresh regulatory scrutiny against a generally risk-on tape. Here’s what investors need to know. - Hims & Hers Health shares are trending higher. Why is HIMS stock trading higher? ## What Is Driving Hims & Hers Health’s Stock Today? The FTC is reportedly preparing a lawsuit alleging Hims & Hers unlawfully shared sensitive customer health data with online advertisers and used deceptive billing and cancellation practices. The report specifically names **Meta Platforms** and **Snap Inc** as ad firms tied to the alleged data flow via tracking technologies. In response, the company said the case ignores evidence it provided during a nearly three-year investigation and that it plans to vigorously defend against what it called "baseless claims." Hims is also navigating sentiment headwinds into earnings after **Jim Cramer** called the stock "controversial" and said he’d rather own **Eli Lilly**. ## HIMS Stock: Critical Levels To Watch Friday’s bounce is happening from a technically important area: the stock is now just 0.7% above its 100-day SMA ($27.51), while still trading 14.9% below its 20-day SMA ($32.54) and 9.8% below its 50-day SMA ($30.72). That mix usually reads as "trying to base," but with overhead supply still close enough to cap rallies. Momentum is the bigger issue right now: MACD is below its signal line and the histogram is negative, which points to upside pressure cooling unless buyers can reassert control. Even with the bullish moving-average backdrop (the golden cross in July), the stock still needs to reclaim the $30.00 area to shift the near-term trend back toward the bulls. - **Key Resistance**: $30.00 — a round-number ceiling that also sits near the 50-day SMA/EMA zone where rebounds can stall ## HIMS Stock Price Action on Friday **HIMS Stock Price Activity:** Hims & Hers Health shares were up 2.44% at $27.70 at the time of publication on Friday, according to Benzinga Pro data. **Read Also: Moleculin Biotech Stock Is Sinking Friday: What's Going On?** *Image: Shutterstock* ### Related Stocks - [HIMS.US](https://longbridge.com/en/quote/HIMS.US.md) - [HIMZ.US](https://longbridge.com/en/quote/HIMZ.US.md) - [HIMY.US](https://longbridge.com/en/quote/HIMY.US.md) - [SNAP.US](https://longbridge.com/en/quote/SNAP.US.md) - [HIYY.US](https://longbridge.com/en/quote/HIYY.US.md) - [META.US](https://longbridge.com/en/quote/META.US.md) - [LLY.US](https://longbridge.com/en/quote/LLY.US.md) - [MBRX.US](https://longbridge.com/en/quote/MBRX.US.md) ## Related News & Research - [13:50 ETHims & Hers Health (NYSE: HIMS) Faces Securities Class Action After FTC Lawsuit Reveal Drives Stock Sharply Lower -- HBSS](https://longbridge.com/en/news/298229527.md) - [15:14 ETHims & Hers Health (NYSE: HIMS) Faces Securities Class Action After FTC Lawsuit Reveal Drives Stock Sharply Lower -- HBSS](https://longbridge.com/en/news/297949538.md) - [10:40 ETINVESTOR DEADLINE ALERT: Hims & Hers Health, Inc. (HIMS) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit](https://longbridge.com/en/news/298113234.md) - [12:00 ETBronstein, Gewirtz & Grossman LLC Urges Hims & Hers Health, Inc. Investors to Act: Class Action Filed Alleging Investor Harm](https://longbridge.com/en/news/298136867.md) - [15:44 ETHIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit](https://longbridge.com/en/news/297822123.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**